Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.
Press releases published on April 23, 2025
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025
GlobeNewswire
·
April 23, 2025
WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research …
Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting
GlobeNewswire
·
April 23, 2025
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 23, 2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, the company issued inducement awards …
Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients
GlobeNewswire
·
April 23, 2025
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the United States Patent and …
Beyond Meat® to Report First Quarter 2025 Financial Results on May 7, 2025
GlobeNewswire
·
April 23, 2025
EL SEGUNDO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, announced today it will report financial results for the first quarter ended March 29, 2025 on Wednesday …
Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event
GlobeNewswire
·
April 23, 2025
Company outlined potential for value creation driven by obe-cel across multiple B cell driven malignancies and autoimmune diseases, including acute lymphoblastic leukemia (ALL), lupus nephritis (LN) and multiple sclerosis (MS) Preliminary data in initial …
Sight Sciences Announces the Release of its Sustainability Report
GlobeNewswire
·
April 23, 2025
MENLO PARK, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today …
Dragonfly Energy Announces First Quarter 2025 Preliminary Net Sales and Adjusted EBITDA
GlobeNewswire
·
April 23, 2025
RENO, Nev., April 23, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today announced preliminary first quarter 2025 Net Sales and …
MARA Schedules Conference Call for First Quarter 2025 Financial Results
GlobeNewswire
·
April 23, 2025
Earnings Webcast and Conference Call Set for Thursday, May 8, 2025 at 5:00 p.m. ET Fort Lauderdale, FL, April 23, 2025 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) ("MARA" or the "Company"), a global leader in leveraging digital asset compute to …
Jewett-Cameron Expands Operational Efficiency Efforts
GlobeNewswire
·
April 23, 2025
NORTH PLAINS, Ore., April 23, 2025 (GLOBE NEWSWIRE) -- Jewett-Cameron Trading Company Ltd. (Nasdaq: JCTC), a company committed to innovative products that enrich outdoor spaces, today announced continued progress in its operational efficiency efforts …
Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
GlobeNewswire
·
April 23, 2025
NEEDHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
Horizon Bancorp, Inc. Reports First Quarter 2025 Results
GlobeNewswire
·
April 23, 2025
MICHIGAN CITY, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- (NASDAQ GS: HBNC) – Horizon Bancorp, Inc. (“Horizon” or the “Company”), the parent company of Horizon Bank (the “Bank”), announced its unaudited financial results for the three months ended March 31, …
Credit Acceptance Announces Timing of First Quarter 2025 Earnings Release and Webcast
GlobeNewswire
·
April 23, 2025
Southfield, Michigan, April 23, 2025 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today that we expect to issue a news release with our first quarter …
Credit Acceptance Recognized with Multiple 2025 Top Workplaces Spring Culture Excellence Awards
GlobeNewswire
·
April 23, 2025
Southfield, Michigan, April 23, 2025 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) is proud to announce our recognition as a 2025 Spring Culture Excellence Top …
Goosehead Insurance, Inc. Announces First Quarter 2025 Results
GlobeNewswire
·
April 23, 2025
– Total Revenue Increased 17% and Core Revenue* Grew 17% over the Prior-Year Period – – Total Written Premium increased 22% to $1.0 billion over the Prior-Year Period – – Net Income of $2.6 million versus Net Income of $1.8 million a year ago – – …
Churchill Downs Incorporated Reports 2025 First Quarter Results
GlobeNewswire
·
April 23, 2025
LOUISVILLE, Ky., April 23, 2025 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (Nasdaq: CHDN) (the "Company", "CDI", "we") today reported business results for the first quarter ended March 31, 2025. Company Highlights First quarter 2025 financial results …
Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts
GlobeNewswire
·
April 23, 2025
First U.S. patient dosed in ATALANTA-1 study of GLPG5101 Mantle cell lymphoma (MCL), a high-unmet-need hematological malignancy, selected as lead indication for the GLPG5101 program; Pivotal development planned to start in 2026 and aiming for approval in …
Galapagos rapporteert resultaten over het eerste kwartaal van 2025, recente hoogtepunten en verwachtingen op korte termijn
GlobeNewswire
·
April 23, 2025
Eerste Amerikaanse patiënt gedoseerd in ATALANTA-1 studie met GLPG5101 Mantelcellymfoom (MCL), een hematologische maligniteit met een hoge onvervulde behoefte, geselecteerd als hoofdindicatie voor het GLPG5101-programma; pivotale ontwikkeling gepland voor …
Verses AI Inc. Announces Proposed Public Offering of Securities
GlobeNewswire
·
April 23, 2025
VANCOUVER, British Columbia, April 23, 2025 (GLOBE NEWSWIRE) -- Verses AI Inc. (CBOE: VERS)(OTCQB: VRSSD) (“Verses” or the “Company”) is pleased to announce an offering (the “Offering”) of securities in Canada under the base shelf prospectus of the Company …
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
April 23, 2025
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …